Press Release
Terumo Announces Change of Executive Officers
TOKYO, JAPAN – February 7, 2024 – Terumo Corporation (TSE: 4543) hereby
announces that it has resolved a change of its Executive Officers as follows.

Name

1. Change of Director (As of April 1, 2024)
New position

Current position

Director and Corporate Advisor
Shinjiro Sato

*It is scheduled that he will retire fromthe position of Director at the Annual
General Meeting of Shareholders tobe held on June 26, 2024.

Director and Corporate Advisor
Shoji Hatano*It is scheduled that he will retire fromthe position of Director at the Annual
General Meeting of Shareholders tobe held on June 26, 2024.

Name

Director and Chief Executive Officer

Director and Group Senior
Managing Executive Officer
Corporate Affairs Dept.
Legal and Compliance Division
Intellectual Property Dept.
Terumo Medical Pranex
Terumo Call Center
IT Planning Dept.

2. New Candidate for Director (As of June 26, 2024)
New position

Director and Chief Executive Officer
Hikaru Samejima*It is subject to the approval at theAnnual General Meeting ofShareholders and the Board of

Directors to be held on the same day.

Director and Group Senior
Managing Executive Officer
Toshihiko Osada*It is subject to the approval at theAnnual General Meeting ofShareholders to be held on the sameday.

Current position
Group Senior Managing Executive
Officer*Scheduled to assume Chief Executive
Officer as of April 1, 2024

Group Senior Managing Executive
Officer3. Change of Group Executive Officer and Executive Officer (As of April 1, 2024)
Name
New position
Current position
Group Managing Executive Officer: GMEO

Hikaru Samejima

Chief Executive Officer

Toshihiko OsadaGroup Senior Managing Executive
Officer
In charge of Innovation;
R&D Division
DX Promotion Dept.
Intellectual Property Dept.
Clinical Development Dept.
Terumo Medical Pranex

Antoinette GawinKazunori Hirose

Fumihisa Hirose

Group Senior Managing Executive
OfficerPresident, Blood and Cell
Technologies Company
President and CEO, Terumo BCT
Holding Corp.

Director and Group Managing
Executive Officer
In charge of Global Supply Chain,
Quality and EHS;
Quality, Post-Market Surveillance
and Vigilance Division
Operations Division
EHS Dept.
Regulatory Affairs Dept.
Group Managing Executive Officer
President, Cardiac and VascularCompany
Division President, Interventional
Systems Division, Cardiac andVascular Company

Group Senior Managing Executive
OfficerPresident, Medical Care Solutions
CompanyGroup Senior Managing Executive
OfficerPresident, Cardiac and VascularCompanyDivision President, Interventional
Systems Division, Cardiac andVascular Company
Group Managing Executive Officer
President, Blood and Cell
Technologies Company
President and CEO, Terumo BCT
Holding Corp.
Director and Group Managing
Executive Officer
Chief Manufacturing Officer (CMO)
Quality, Post-Market Surveillance
and Vigilance Division
Regulatory Affairs and ClinicalDevelopment Division
Operations Division
Group Managing Executive Officer
General Manager, Strategic Planning
Dept.
Chief Technology Officer (CTO)
R&D DivisionNorimasa Kunimoto

Itaru Sakaguchi

Director and Group Managing
Executive Officer
In charge of Corporate Value
Promotion;
Corporate Affairs Dept.
Legal and Compliance DivisionCorporate CommunicationDivision
Japan Sales Dept.
Terumo Call Center
Group Managing Executive Officer
President, Medical Care Solutions
Company

Director and Group Managing
Executive Officer
Corporate Value Promotion Division
Human Resources Division
Japan Sales Dept.

Senior Executive Officer
Chief Operations Officer (COO),
Interventional Systems Division,
Cardiac and Vascular Company
President, Terumo Yamaguchi Corp.

Group Executive Officer: GEO

Hiroshi Yagi

Noritsugu Fujita

Toshiyuki Akaike

Chris Williams

Cindy NgGroup Executive Officer
Chief Operations Officer (COO),
Interventional Systems Division,
Cardiac and Vascular Company
President, Terumo Yamaguchi Corp.

Executive Officer
General Manager, Ashitaka Factory,
Interventional Systems Division,
Cardiac and Vascular Company

Group Executive Officer
Division President, Hospital Care
Solutions Division, Medical CareSolutions Company

Executive Officer
Division President, Hospital Care
Solutions Division, Medical CareSolutions Company

Group Executive Officer
Division President, PharmaceuticalSolutions Division, Medical Care
Solutions Company

Executive Officer
Division President, PharmaceuticalSolutions Division, Medical Care
Solutions Company

Group Executive Officer
Senior Vice President, GlobalManufacturing, Terumo Blood andCell Technologies Inc.

Senior Vice President, GlobalManufacturing, Terumo Blood andCell Technologies Inc.

Group Executive Officer
Senior Vice President, Global
Commercial, Terumo Blood andCell Technologies Inc.

Senior Vice President, Global
Commercial, Terumo Blood and Cell
Technologies Inc.

Masanobu Yano

Kenichi Hata

Jin HagimotoGroup Executive Officer
Regional Representative, China
President and CEO, Terumo (China)
Holdings Co., Ltd.

Deputy General Manager, Terumo(China) Holdings Co., Ltd.

Group Executive Officer
Chief Financial Officer (CFO)
Acting Chief Information Officer(CIO)
General Manager, CFO OfficeController Dept.
Treasury Dept.
Tax Dept.
J-SOX Office
IT Planning Dept.
Global Business Services (GBS)

Deputy Chief Accounting andFinancial Officer (CAFO)
General Manager, CAFO OfficeGroup Executive Officer
General Manager, Strategic
Planning Dept.

General Manager, IR Dept.
General Manager, Corporate
Sustainability Dept.

※Masayuki Maruta (Current: Group Executive Officer, Regional Representative, China),
Naoki Muto (Current: Group Executive Officer, Chief Accounting and Financial Officer(CAFO)) will retire from the current positions as of March 31, 2024.

Executive Officer: EO

Toshio Nakashima

Jin Nishizaki

Shinji Omori

Executive Officer
General Manager, Ashitaka Factory,
Cardiac and Vascular Company
Deputy Chief Operations Officer(COO), Interventional Systems
Division, Cardiac and VascularCompany
Executive Officer
General Manager, Japan Sales
Dept.
Terumo Call Center

Executive Officer
Chief Technology Officer (CTO)
General Manager, DX Promotion
Dept.
R&D Division

Executive Officer
Chief Quality Officer (CQO)
General Manager, Quality Assurance
Dept.
Post-Market Surveillance andVigilance Dept.
Executive Officer
General Manager, Japan Sales Dept.

General Manager, DX Promotion
Dept.

Jun Yamashita

Executive Officer
Chief Quality Officer (CQO)
Quality Assurance Dept.
Post-Market Surveillance andVigilance Dept.

Vice President Growth Ventures
Quality, Terumo Blood and Cell
Technologies Inc.

Takumi Uchida

Executive Officer
Chief Operations Officer (COO)
Medical Care Solutions Company

General Director, Terumo VietnamCo., Ltd.

※Kazuhisa Senshu (Current: Senior Executive Officer, Chief Clinical and Regulatory
Affairs Officer (CRAO)) will retire from the current position as of March 31, 2024.

About Terumo

Terumo (TSE:4543) is a global leader in medical technology and has been committed
to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo andoperating globally, Terumo employs more than 30,000 associates worldwide toprovide innovative medical solutions in more than 160 countries and regions. Thecompany started as a Japanese thermometer manufacturer, and has been supporting
healthcare ever since. Now, its extensive business portfolio ranges from vascularintervention and cardio-surgical solutions, blood transfusion and cell therapy
technology, to medical products essential for daily clinical practice. Terumo will furtherstrive to be of value to patients, medical professionals, and society at large.